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ABSTRACT
Small regulatory RNAs (sRNAs) from bacterial
chromosomes became the focus of research over
the past five years. However, relatively little is
known in terms of structural requirements, kinetics
of interaction with their targets and degradation in
contrast to well-studied plasmid-encoded antisense
RNAs. Here, we present a detailed in vitro analysis
of SR1, a sRNA of Bacillus subtilis that is involved in
regulation of arginine catabolism by basepairing
with its target, ahrC mRNA. The secondary struc-
tures of SR1 species of different lengths and of the
SR1/ahrC RNA complex were determined and func-
tional segments required for complex formation
narrowed down. The initial contact between SR1
and its target was shown to involve the 50 part of the
SR1 terminator stem and a region 100bp down-
stream from the ahrC transcriptional start site.
Toeprinting studies and secondary structure prob-
ing of the ahrC/SR1 complex indicated that SR1
inhibits translation initiation by inducing structural
changes downstream from the ahrC RBS.
Furthermore, it was demonstrated that Hfq, which
binds both SR1 and ahrC RNA was not required
to promote ahrC/SR1 complex formation but
to enable the translation of ahrC mRNA. The
intracellular concentrations of SR1 were calculated
under different growth conditions.
INTRODUCTION
Small regulatory RNAs (sRNAs) are expressed in both
prokaryotes and eukaryotes, primarily as posttranscrip-
tional regulators. Over the past six years, about 70 sRNAs
have been discovered in E. coli, and about 20 of them have
been assigned a function. Many of these trans-encoded
RNAs are involved in metabolic processes [e.g. Spot42,
DsrA, RprA, RyhB, SgrS, GadY, reviewed in (1)] and at
least eight sRNAs regulate the expression of membrane
proteins [reviewed in (2)]. To date, relatively few
systematic searches have been performed in Gram-positive
bacteria. Among the recently discovered sRNAs in Gram-
positive hosts are RatA from the Bacillus subtilis
chromosome (3), which came up in a systematic search
(4) together with 12 other sRNAs that proved to be
sporulation-controlled, but still await the identiﬁcation of
their targets (5). Furthermore, in addition to the well-
studied RNAIII from Staphylococcus aureus (6), 12 novel
sRNAs from Staphylococcus aureus pathogenicity islands
have been detected (7) as well as three Hfq-binding sRNAs
of Listeria monocytogenes with still unknown function (8),
and nine novel sRNAs from Listeria monocytogenes
within intergenic regions found by in silico-based
approaches (9). Additionally, more than 100 potential 6S
RNA species have been identiﬁed by bioinformatics
approaches, and many of them were veriﬁed experimen-
tally, among them two 6S RNA species in B. subtilis
(10,11). Still, the identiﬁcation of mRNA targets of the
recently discovered sRNAs is a challenging issue, and has
been successful only in less than one-third of all cases.
One important hallmark of many trans-encoded reg-
ulatory RNAs from E. coli is their ability to bind the
Sm-like abundant RNA chaperone Hfq (12). While
several sRNAs have been found to require Hfq for their
stability, some were shown to need Hfq for eﬃcient
complex formation with their target RNA (13,14). For
DsrA/rpoS/Hfq, the pathway of complex formation has
been investigated by biophysical techniques (15).
However, for sRNAs from Gram-positive bacteria, the
putative function of Hfq is still elusive. At least in one
case, staphylococcal RNAIII/spa interaction, no inﬂuence
of Hfq has been found (16).
In contrast to the cis-encoded sRNAs from accessory
genetic elements like plasmids, phages, transposons that
have been studied in detail over the past 25 years [reviewed
in (17)], relatively little is known about structural
requirements, binding kinetics and mechanisms or degra-
dation pathways of these new trans-encoded regulatory
sRNAs. Although complexes between sRNA and mRNA
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cases secondary structures of such complexes predicted
by Mfold have been conﬁrmed by experimental secondary
structure probing. These include MicF/ompF (18),
Spot42/galK (19), RyhB/sodB (20), MicA/ompA (14,21)
from E. coli and RNAIII/spa from Staphylococcus aureus
(22). So far, the region of initial contact between a trans-
encoded sRNA and a target RNA sharing more than one
complementary region has not been narrowed down.
The mechanism of action has been proposed in some
cases, but not always corroborated by a combination of
in vivo and in vitro experiments.
The 205-nt untranslated RNA SR1 from the B. subtilis
genome was found in our group by a combination of
computer predictions and northern blotting (23).
Recently, we have shown that SR1 is a bona ﬁde antisense
RNA that acts by basepairing with its primary target,
ahrC mRNA, the transcriptional activator of the rocABC
and rocDEF arginine catabolic operons (24). In vitro
translation data and translational reporter gene fusions
suggested that SR1 might inhibit ahrC translation at a
post-initiation stage. Hfq was shown to be dispensable for
the stability of SR1.
Here, we provide a detailed in vitro characterization of
SR1 and the SR1/ahrC complex with and without Hfq.
We determined the region of initial contact between SR1
and ahrC. Furthermore, a combination of toeprinting
and SR1/ahrC complex probing studies demonstrated
that SR1 inhibits translation initiation of ahrC mRNA
by inducing structural changes between the ahrC
SD sequence and the ﬁrst complementary region G.
In contrast to many E. coli sense/antisense systems, Hfq
was shown to be exclusively required for translation of
ahrC RNA, but not for promoting the SR1/ahrC
interaction. The intracellular concentration of SR1 in
B. subtilis was calculated to be 30nM in log phase and
315nM in stationary phase in complex TY medium.
MATERIALS AND METHODS
Enzymes andchemicals
Chemicals used were of the highest purity available. Taq
DNA polymerase was purchased from Roche or
SphaeroQ, Netherlands, respectively, RNA ligase from
New England Biolabs and Thermoscript reverse tran-
scriptase and M-MuLV reverse transcriptase from
Invitrogene and Fermentas, respectively. Firepol poly-
merase was purchased from Solis Biodyne, Estonia.
Strains, media and growth conditions
Escherichia coli strains DH10B and ER2566(hfq::kan)
were used for cloning and for expression of the B. subtilis
hfq gene, respectively. Bacillus subtilis strains DB104
(25) and E. coli strains were grown in complex TY
medium (24).
InvitrotranscriptionandsecondarystructureanalysisofSR1,
ahrC and SR1/ahrC complexes
In vitro transcription and partial digestions of in vitro
synthesized, 50-end-labelled SR1 and ahrC RNA species
with ribonucleases T1, T2 and V were carried out as
described (26). For the analysis of SR1/ahrC complexes
with T1, T2 and V, either SR1 or ahrC were 50 end-labelled
and a 6- to 60-fold excess of the cold complementary RNA
was added prior to RNase digestion.
Analysis ofRNA–RNA complexformation
Both ahrC RNA and SR1 were synthesized in vitro from
PCR-generated template fragments with primer pairs indi-
cated in Table 1 Supplementary Data. SR1/ahrC complex
formation studies were performed as described previously
(24). Complex formation in the presence of Hfq was assayed
in TMN buﬀer (24) using puriﬁed Hfq from B. subtilis.
Purification of B. subtilis Hfq
For the puriﬁcation of B. subtilis Hfq, the IMPACT
TM-
CN system from New England Biolabs was used.
To prevent the puriﬁcation of E. coli/B. subtilis Hfq-
heterohexamers, E. coli strain ER2566(hfq::kan) was
transformed with plasmid pTYB11-BsHfq. (All plasmids
used in this study are summarized in Table 1). The
resulting strain was grown at 378C till OD560=0.7,
induced with 0.25mM IPTG, and grown at 188C for
further 18h. The fusion protein was puriﬁed by aﬃnity
chromatography on a chitin column as described by the
manufacturer. On-column cleavage was performed with
20mM Tris-HCl pH 8.0, 500mM NaCl and 50mM DTT
for 20h at room temperature. Millipore microcon
columns were used to concentrate the eluted Hfq protein
and to exchange the buﬀer for 50mM Tris-HCl pH 8.0.
The puriﬁed protein was stored at 48C.
Construction of plasmidsfor thein vivoreporter genetest
system
For the construction of the three translational fusions,
chromosomal DNA from B. subtilis DB104 was used as
Table 1. Plasmids used in this study
Plasmid Description Reference
pTYB11-BsHfq pTYB11 vector with B. subtilis hfq gene P. Valentin-Hansen
pGF-BgaB Integration vector for amyE gene, heat-stable
b-galactosidase from B. stearothermophilus without SD for translational fusions, Km
R,A p
R
27
pGGA4 pGF-BgaB with nt 1 to 119 of ahrC this study
pGGA6 pGF-BgaB with nt 1 to 113 ahrC this study
pGGA7 pGF-BgaB with nt 1 to 279 of ahrC but lacking nt 102–112 this study
pGGA8 pGF-BgaB with nt 1 to 119 of ahrC, but 2nt exchange this study
4332 Nucleic Acids Research, 2007, Vol. 35, No. 13template in three PCR reactions with upstream primer
SB979 and the corresponding downstream primers
SB980 (pGGA4), SB987 (pGGA6) and SB1065
(pGGA8). All fragments were digested with BamHI and
EcoRI and inserted into the BamHI/EcoRI vector
pGF-BgaB (27) encoding the promoterless heat-stable
b-galactosidase from B. stearothermophilus. For the
construction of plasmid pGGA7 carrying an internal
deletion of 11bp (nt 102 to 112) of ahrC, a two-step PCR
with outer primers SB979 and SB976 and internal
primers SB989 and SB988 was performed on chromoso-
mal DNA as template, the third PCR product
obtained with SB979 and SB976 cleaved with BamHI
and EcoRI and inserted into the BamHI/EcoRI vector
pGF-BgaB.
Toeprinting analysis
The toeprinting assays were carried out using 30S
ribosomal subunits, ahrC483 mRNA and tRNA
fMet
basically according to (28). The 30S ribosomal subunits
devoid of initiation factors were prepared from E. coli
strain MRE600 essentially as described by Spedding (29).
The 50-[
32P]labelled ahrC-speciﬁc oligonucleotide SB1068
(50 TAC CGT GGC CTG CGT TAC) complementary to
ahrC mRNA was used as a primer for cDNA synthesis in
the toeprinting reactions. An aliquot of 0.04pmol of ahrC
mRNA annealed to primer SB1068 was incubated at 378C
without or with 0.4pmol of 30S subunits and 8pmol of
uncharged tRNA
fMet (Sigma) before supplementing with
1ml M-MuLV-RT (80 units). cDNA synthesis was
performed at 378C. Reactions were stopped after 10min
by adding formamide loading dye. The samples were
separated on a denaturing 8% polyacrylamide gel. For the
analysis of the eﬀect of sRNAs on 30S complex formation,
ahrC483 mRNA and the corresponding sRNA were
incubated for 15min at 378C before the addition of 30S
ribosomes and initiator tRNA. Toeprint eﬃciency was
determined by PhosphorImaging using the Image-quant
software package (PC-BAS 2.0).
Preparation of totalRNA andnorthern blotting
Preparation of total RNA and northern blotting were
carried out as described previously (23).
RESULTS
Secondary structures of SR1and truncated SR1species
So far, only for a few chromosomally encoded regulatory
sRNAs, secondary structures have been determined
experimentally. Examples include MicF (18), OxyS (30),
RNAIII of S. aureus (31), DsrA (32), Spot42 (19), RyhB
(20) and MicA (14,21). Since computer-predicted RNA
structures often deviate from experimentally determined
ones [e.g. RNAIII of pIP501 (33) or RNAI/RNAII of
pT181 (34)], we performed limited digestions with
structure-speciﬁc ribonucleases in vitro to determine the
secondary structure of SR1. The wild-type SR1 (205nt) as
well as the 30 truncated species SR1132, the 50 truncated
species SR198 and the 50 and 30 truncated species SR178
were 50-end labelled, gel-puriﬁed and treated with RNases
T1 (cleaves 30 of unpaired G residues), T2 (unpaired
nucleotides with a slight preference for A residues) and V1
(double-stranded or stacked regions). Figure 1A shows
an analysis of SR1205 and the truncated species SR1132
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Figure 1. Secondary structures of SR1 species of diﬀerent lengths.
(A) Secondary structure probing of wild-type SR1 (205nt) and truncated
species SR1132 with RNases. Puriﬁed, 50 end-labelled SR1 was subjected
to limited cleavage with the RNases indicated. The digested RNAs were
separated on 8% denaturing gels. Autoradiograms are shown. RNase
concentrations used were: T1: 10
 2U/ml (1:50), T2: 10
 1U/ml (1:500), V1:
10
 1U/ml (1:10), C, control without RNase treatment, L, alkaline ladder.
(B) Proposed secondary structure of SR1. A structure consistent with the
cleavage data in Figure 1A and additional experiments (data not shown)
is depicted. Major and minor cuts are indicated by symbols (see box).
The three main stem-loops SL1, SL2 and SL3 are indicated.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4333whereas Figure 2B contains the schematic representation
of the structure of SR1205 derived from the cleavage data.
The experimentally determined structure for wild-type
SR1 comprises three main stem-loops: SL1 (nt 1 to 112),
SL2 (nt 138 to 154) and the terminator stem-loop SL3 (nt
173 to 203) interrupted by two single-stranded regions
SSR1 (nt 113 to 137) and SSR2 (nt 155 to 172). It deviates
from the structure predicted with Mfold in the 50 as well as
in the 30 portion: The 50 part was found to be single-
stranded between nt 38 and 51, and the double-stranded
stem proved to be much longer than predicted and
comprises 20 paired nucleotides (nt) interrupted by three
internal loops or bulged-out bases, respectively, compared
to only 10 paired nt in the predicted structure. For the 30
part, two stem-loops and the terminator stem-loop were
predicted by Mfold, whereas the structure probing data
support in addition to the terminator stem-loop only the
second stem-loop SL2 in the centre of a long single-
stranded region.
Structure probing of the 50 132nt of SR1 (Figure 1A,
right part) showed that this portion of the molecule folded
independently and exactly as in the full-length sRNA. The
secondary structure for the 30 98nt of SR1 contained
exactly the terminator stem-loop as in wild-type SR1 (not
shown) and the secondary structure for SR178 comprising
nt 109 to 186 revealed the single stem-loop SL2
surrounded by single-stranded regions as expected (not
shown).
The information on the secondary structures of the
truncated derivatives was necessary to assess the data on
complex formation between diﬀerent SR1 species and its
target, ahrC mRNA.
Figure 1. Continued.
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Previously, we have shown that SR1 binds to the 376 30 nt
of ahrC mRNA (ahrC376, Figure 2C) with an equilibrium
dissociation rate constant KD of 3.21 10
 7M (24). Since
seven regions of complementarity have been predicted
between SR1 and ahrC mRNA [(24) and Figure 2C],
we intended to narrow down the segment of SR1 that is
required for the initial contact with its target. To this end,
SR1 species of diﬀerent lengths were generated by in vitro
transcription with T7 RNA polymerase, 50 end-labelled,
gel-puriﬁed and used for binding assays with the ahrC376
RNA. The results are shown in Figure 2A: 30 truncated
SR1 derivatives SR1132 and SR1104 comprising only stem-
loop SL1 and lacking SL2 and the terminator stem-loop,
were not able to form complexes with ahrC mRNA even
at 400nM. In contrast, 50 truncated species SR178
comprising only the single-stranded region, SL2 and the
50 half of the terminator stem-loop, was as eﬃcient in
complex formation as SR1186, a species that only lacked
the 30 half of the terminator stem-loop, but otherwise
contained the complete wild-type sequences and struc-
tures. In accordance with these data, both SR1169 lacking
SL3 completely and SR161, lacking SL1 and SL3, were
signiﬁcantly impaired in the interaction with their target
and only at 400nM ahrC mRNA, a weak complex was
observed.
From these results we can conclude that for eﬃcient
complex formation between SR1 and ahrC mRNA, SL1
and the 30 half of SL3 are not required. Furthermore, the
opening of the terminator stem-loop SL3 seems to be
essential for an eﬃcient interaction and a sequence located
in the 50 half of SL3 proved to be important for the
contact between antisense-RNA and target.
To analyse the regions of ahrC required for eﬃcient
pairing with SR1, ﬁve 50 labelled ahrC RNA species
(shown schematically in Figure 2C) were used in complex
formation experiments with SR1186 (Figure 2B). As
expected, labelled ahrC376 comprising nt 108 to 483 of
ahrC RNA, but lacking the 50 part and the SD sequence of
Figure 2. Binding assays of wild-type and truncated SR1/ahrC RNA pairs. Binding experiments were performed as described in Materials and
Methods section. Autoradiograms of gel-shift assays are shown. The concentration of unlabelled ahrC RNA species or SR1 species is indicated.
F, labelled RNA, D duplex between SR1 and ahrC RNA. (A) Binding assays with wild-type and truncated SR1 derivatives. SR1 species were 50 end-
labelled with [g
32P]-ATP and used in at least 10-fold lower equimolar amounts compared to the targets. ahrC376 comprising the 30 part of ahrC
mRNA with nt 113 to 483 was used in all cases. Above, the schematic representation of the SR1 species is shown. (B) Binding assays with wild-type
and truncated ahrC species. ahrC RNA species were 50 end-labelled with [g
32P]-ATP and used in at least 10-fold lower equimolar amounts compared
to SR1186.( C) Overview on the ahrC mRNA species used in this work. The sequence of the ahrC gene is shown. Regions A0 to G0 complementary to
SR1 are indicated by grey boxes, the SD sequence is underlined. Start and stop codon are shown in Italics. Below, a schematic representation of the
5 ahrC-mRNA species used in this work is shown. Black rectangle, SD sequence. grey boxes, regions complementary to SR1.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4335ahrC formed a complex with unlabelled SR1186 with the
same KD as determined previously for the labelled
SR1/unlabelled ahrC376 pair. The same eﬃciency for
complex formation was observed for ahrC88 containing
region G0 but lacking the SD sequence. By contrast,
labelled ahrC136 and ahrC196 comprising the 50 136 and
196nt of ahrC mRNA, respectively, including SD
sequence and region G0, were signiﬁcantly impaired in
complex formation with unlabelled SR1186. The complete
ahrC483 mRNA including 50 end, SD and all complemen-
tary regions to SR1 formed a weak complex with SR1 only
at 400nM concentration. These results suggest that the
SD sequence of ahrC mRNA might be sequestered by
intramolecular basepairing and that a factor might be
needed to facilitate ribosome binding.
Secondary structure ofthe SR1/ahrC complex
The results from the binding assays indicate that SR178 is
suﬃcient for eﬃcient complex formation with ahrC
mRNA and that without opening of the 50 half of the
terminator stem-loop no eﬃcient complex can form.
To investigate the alterations in the secondary structures
of SR1 and ahrC upon pairing, the secondary structure of
the SR1186/ahrC376 complex was determined. To ascertain
alterations in the SR1 structure, labelled SR1186 was
incubated with a 6- to 60-fold excess of unlabelled ahrC
RNA, the complex was allowed to form for 5min at 378C,
and, subsequently, partially digested with RNases T1, T2
and V1. In parallel, free SR1186 was treated in the same
way. Figure 3A shows the result. As expected, no
signiﬁcant alterations were observed within the 50 112nt
of SR1 that contain only region A (nt 15 to 19)
complementary to ahrC. By contrast, signiﬁcant altera-
tions in the T1, T2 and V cleavage pattern were observed
within the other six complementary regions B, C, D, E, F
and G (Figure 3A, right half). The data are summarized in
Figure 3C: Whereas in region B, only one reduced T1 cut
was detected at G113, drastic alterations were observed in
both regions C and G: In C, all 9nt complementary to
ahrC showed reduced T2 cleavages, G126 and G127
exhibited reduced T1 cleavage and at U123 and U125,a n
induction of V1 cleavage was detected indicating that this
region became double-stranded upon pairing with ahrC.
The same was true for region G, where the cleavage
pattern at all positions was altered compared to free SR1:
nt 175 to 181 showed a decreased T2 cleavage, among
them G176 and G181 a reduced T1 cleavage, whereas at
U180 and G181 new V cuts appeared. Fewer changes were
found in regions D, E and F, where G133 (region D), U146
and A147 (region E) and G156,U 157 and U158 (region F)
were not single-stranded anymore and, instead, U132 and
U133 (region D), A148 and A149 (region E) as well as U155
and G156 (region F) showed induced V cleavages, i.e.
became double-stranded.
To further substantiate these results, secondary struc-
ture probing was performed with a complex formed
between labelled ahrC and a 6- to 60-fold excess of
unlabelled SR1. To corroborate our previous hypothesis
that SR1 does not inhibit the translation initiation at the
ahrC SD sequence, both the complex between ahrC136
(50 136nt of ahrC including SD sequence and region G0)
and the complex between ahrC376 (lacking the 50 112nt of
ahrC including SD, but comprising all regions comple-
mentary to SR1) were probed with RNases T1, T2 and V.
The results are shown in Figure 3B and are summarized in
Figure 3D: In the case of ahrC376, induced V cuts were
visible in regions E and G. Furthermore, between region E
and D and in region C, T2 cuts were induced which is
expected when one strand of a double-stranded region
interacts with SR1, and the other half becomes, conse-
quently, single-stranded. The same holds true for the
induced T1 cuts in region B and the induced T2 cut in the
region upstream of B.
The lower part of Figure 3B presenting the results of
SR1/ahrC136 interaction clearly shows that the ahrC
SD sequence itself was not aﬀected upon addition of
increasing amounts of unlabelled SR1. Surprisingly,
a number of alterations could be observed further
downstream from it and upstream of complementary
region G0. In particular, prominent V cuts were induced at
nt 40, nt 46 to 48, nt 52, nt 56, nt 71 and nt 90,
accompanied by induced T2 cuts around nt 56 and 74, 75,
77 and 78 (Figure 3B left and Figure 3D). These data
suggest that binding of SR1 causes structural changes in
the 50 part of ahrC mRNA between the SD sequence and
region G0.
The initial contact between SR1and ahrC RNA requires
complementary region G
As published previously (24), one out of seven regions of
complementarity between SR1 and ahrC RNA comprises
nt 176 to 181 within the 50 half of the SR1 terminator
stem-loop SL3 (designated G) and nt 113 to 118 of ahrC
mRNA (designated G0). If these two regions were involved
in a ﬁrst contact between SR1 and ahrC RNA, nucleotide
exchanges in either SR1 or ahrC RNA should impair or
abolish complex formation, and compensatory mutations
should, at least partially, restore binding. To test this
hypothesis, three mutated SR1186 species with either
a 10nt exchange (50AGCAUGCGGC to 50
UCGUACGCCG) between nt 176 and 185 denoted
SR1186_G10, a 6nt exchange (50AGCAUG to
50UCGUAC), denoted SR1186_G6 or a 2nt exchange
(G177C178 to T177T178) denoted SR1186_G2, were assayed
in complex formation with wild-type ahrC88 comprising nt
109 to 196 of ahrC mRNA (region G0). The 6 and 10nt
exchanges were designed such that the GC/AU content of
the region was not altered compared with the wild-type.
As shown in Figure 4A, no interaction between these three
mutated SR1 species and wild-type ahrC RNA was
observed. By contrast, the exchange of only C178 to G
(SR1186_G1) did not impede complex formation, suggest-
ing that either G177 is most important for the initial
contact or that substitution of one nucleotide is not
suﬃcient to cause an eﬀect. Interestingly, when ahrC
RNA88_G02, a derivative of the same length carrying the
compensatory mutations to SR1186_G2 was used, binding
could be restored (Figure 4A and B) conﬁrming a speciﬁc
basepairing interaction between SR1 and ahrC mRNA.
When a longer ahrC376 RNA comprising all seven
4336 Nucleic Acids Research, 2007, Vol. 35, No. 13complementary regions G0 to A0 was analysed, binding
was abolished by the above-mentioned mutations too, and
partially restored with the compensatory mutation
ahrC376_G02 mRNA (not shown). These data indicate
that the complementary region G of SR1 (nt 176 to 181)
plays an important role for the recognition of ahrC
mRNA.
To investigate the contribution of the other regions of
SR1 complementary to ahrC RNA to eﬃcient binding
with its target, two SR1186 species carrying 9nt exchanges
each in either region C (nt 119 to 127)—SR1S5—or region
E and the ﬁrst 2nt of region F (comprising nt 146 to
154)—SR1S6—were analysed for complex formation with
ahrC RNA carrying the wild-type or mutated regions
(Figure 4C). Complex formation was signiﬁcantly
impaired in both cases: SR1S5 exhibited about 10-fold
and SR1S6 about 30-fold decreased eﬃciency to pair with
ahrC RNA. A combined substitution of regions C, E and
50 F (SR1S7) or a combined exchange of regions C, D, E
and 50 F (SR1S9) resulted in a complete loss of pairing.
Figure 4D shows a schematic representation of the four
mutated SR1186 species.
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Figure 3. Secondary structure probing of the SR1/ahrC complex. (A) Alterations in the SR1 secondary structure upon complex formation with ahrC
mRNA. Puriﬁed, 50 end-labelled SR1186 (13nM) was incubated with increasing amounts of unlabelled ahrC376 (80, 200 and 800nM), complex
allowed to form for 5min at 378C and subjected to limited cleavage with the RNases indicated. The digested RNAs were separated on 8%
denaturing gels. Autoradiograms are shown. RNase concentrations used were: T1: 10
 2U/ml, T2: 10
 1U/ml, V1: 10
 1U/ml C, control without RNase
treatment, L, alkaline ladder. Left; entire gel. Right, long run of the same samples allowing a better separation of the complementary regions B, C,
D, E and F. Nucleotide positions are included. Altered T1, T2 and V cleavages are indicated by the symbols shown in the box. Right half, below:
SR178: For a better resolution of the complex within complementary regions F and G, the secondary structure of the complex between SR178
(6.25nM) and ahrC376 (80, 200, 800 and 1600nM) was mapped, the same concentrations of T1, T2 and V were used and the products separated by a
long run on an 8% gel. (B) Alterations in the ahrC secondary structure upon complex formation with SR1. Puriﬁed, 50 end-labelled ahrC136 or
ahrC376 (13nM) was incubated with increasing amounts of unlabelled SR1186 (80, 200 and 800nM), complex formation, cleavage and gel separation
were performed as above. (C) Schematic representation of the SR1 secondary structure with indicated structural changes upon binding to ahrC RNA.
Altered T1, T2 and V cleavages are denoted as shown in the box. Regions complementary to ahrC RNA are highlighted by grey boxes.
(D). Schematic representation of the secondary structure of ahrC136 and ahrC376 with indicated structural changes upon binding to SR1. Altered T1,
T2 and V cleavages are denoted as shown in the box. Regions complementary to SR1 are highlighted by grey boxes. Nucleotide numbering for both
RNAs is as in Figure 2.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4337These data indicate that, although region G is crucial,
regions C, D, E and F contribute to eﬃcient pairing.
Aninvivoreportergenetestsystemconfirmedtheimportance
ofregionGfortheinteractionbetweenSR1andahrCmRNA
To test the importance of region G0 (nt 113 to 118 of
ahrC-mRNA complementary to nt 176–181 of SR1) for
the interaction with SR1 in vivo in B. subtilis, the following
three translational ahrC-BgaB fusions were constructed:
pGGA6 containing nt 1 to 113 but lacking all but one nt
of region G, pGGA4 comprising nt 1 to 119, i.e. the entire
region G+one additional nt, and, hence, no other
complementary region, and pGGA7 identical to pGGA3
(comprising G, F and E, 24) but lacking nt 102 to 112
upstream of G. All fusions were integrated into the amyE
locus of the B. subtilis DB104 chromosome, grown
till OD560 5 (maximal expression of SR1) and
b-galactosidase activities measured. As shown in
Table 2, b-galactosidase activities measured with
pGGA4 and pGGA7 were, in both cases, about 30-fold
lower than that of the pGGA6-integration strain lacking
any complementary region to SR1. Since pGGA4 yielded
the same decrease in b-galactosidase activity compared to
a construct lacking any complementarity with SR1 as our
previous construct pGGA3 that encompassed regions G,
E and F, it can be concluded that region G alone is
suﬃcient to inhibit ahrC translation almost completely.
The results obtained with pGGA7 and pGGA4 exclude
the possibility that the sequences immediately adjacent
to region G are involved in the observed decrease of
b-galactosidase activity, e.g. by providing a cleavage site
for an RNase.
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4338 Nucleic Acids Research, 2007, Vol. 35, No. 13To test whether point mutations in region G0 abolish the
eﬀect of SR1 on ahrC translation, pGGA8 was con-
structed carrying the same 2nt exchange as SR1186_G-2
analysed in the binding assay (Figure 4A), but lacking any
sequences downstream from nt 118 (30 end of region G0)
and integrated into the amyE locus of B. subtilis. The
b-galactosidase activity measured with pGGA8 was nearly
the same as with pGGA6 (Table 2), conﬁrming the in vitro
result that the 2-nt exchange in region G prevented the
interaction between SR1 and ahrC.
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Nucleic Acids Research, 2007, Vol. 35, No. 13 4339Hfq doesnot promotethe interaction between SR1 andahrC
mRNA, butis requiredfor thetranslation of ahrC mRNA
Many small RNAs from E. coli need Hfq for either
stability or their interaction with their targets (see
Introduction section). Previously, we have shown that
Hfq is neither required for the stabilization of SR1 nor
that of ahrC (24). However, in the absence of Hfq, but
presence of SR1, the expression of the downstream SR1
targets, rocABC mRNA and rocDEF mRNA, was about
3- and 6-fold, respectively, increased. Therefore, we
wanted to investigate, whether Hfq is required for the
promotion of complex formation with ahrC RNA.
To investigate whether Hfq binds SR1, diﬀerent
concentrations of puriﬁed B. subtilis Hfq were added to
labelled wild-type SR1 and two 30 truncated species
SR1186 and SR1104, and a gel-shift assay was performed.
As shown in Figure 5A, all three SR1 species bound Hfq
at concentrations of 3–10mM. To analyse binding of Hfq
to ahrC RNA, full-length and truncated ahrC species were
assayed for Hfq binding: As shown in Figure 5B, ahrC136,
ahrC196 and ahrC483 (full length) that contain the SD
sequence, bound Hfq very eﬃciently. By contrast, ahrC376
lacking the SD sequence bound Hfq less eﬃciently than
ahrC483.
Since both SR1 and ahrC RNA bound Hfq, we
analysed whether Hfq is able to promote the complex
formation between both RNAs in vitro. For this purpose,
puriﬁed B. subtilis Hfq was added to a ﬁnal concentration
of 10mM (amount required to bind 50% SR1), to the
mixture of 1.0nM labelled SR1 and diﬀerent amounts of
unlabelled ahrC mRNA, incubated for 15min at 378C and
complexes were separated on 6% native PAA gels.
Although a ternary SR1/ahrC/Hfq complex formed, this
complex was not observed at lower ahrC concentrations
compared to the binary SR1/ahrC complex, and the
amount of this complex did not increase with increasing
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Figure 4. Binding assays of wild-type and mutated SR1/ahrC pairs. Binding experiments were performed as described in the Materials and Methods
section. Autoradiograms of gel-shift assays are shown. The concentration of unlabelled ahrC88 RNA species is indicated. SR1 derivatives were 50 end-
labelled with [g
32P]-ATP and used in at least 10-fold lower equimolar amounts compared to the targets. F, free SR1, D duplex between SR1 and
ahrC RNA. (A) Analysis of mutations in region G. (B) Schematic representation of SR1 with the mutations introduced into region G. (C) Analysis of
mutations in regions C, D, E and F. (D) Schematic representation of the mutated SR1 species. Grey boxes denote the substituted regions.
Table 2. b-Galactosidase activities
Strain 50 ahrC Sequence b-Galactosidase
activity (Miller units)
DB104::pGGA6 113nt (no) 251 28
DB104::pGGA4 119nt (G) 7.6 2
DB104:: pGGA7 280nt (G, F, E,
but nt102–112)
3.5 1.4
DB104:: pGGA8 119nt (G, but 2nt
exchange)
240 35
DB104::pGF-BgaB no 2.9 0.5
DB104::pGGA6 (hfq::cat) 113nt (no) 1.3 0.5
All values represent averages of at least three independent determina-
tions. Plasmid pGF-BgaB is the empty vector. All plasmids contain
ahrC sequences fused in frame to the promoterless, SD less gaB gene
encoding the heat-stable b-galactosidase of B. stearothermophilus
and were inserted into the amyE locus of the B. subtilis chromosome.
b-Galactosidase activities were measured at 558C. In brackets, the
presence of complementary regions to SR1 is denoted.
4340 Nucleic Acids Research, 2007, Vol. 35, No. 13concentrations of unlabelled ahrC RNA (Figure 5C).
In contrast, upon higher concentrations of unlabelled
ahrC RNA ( 100nM), this RNA, apparently, successfully
competed with SR1 for Hfq binding, so that the amount
of unbound labelled SR1 increased again (Figure 5C).
In summary, all these data clearly prove that the RNA
chaperone Hfq does not facilitate the interaction between
SR1 and its target ahrC mRNA.
Figure 5. Analysis of the role of Hfq. (A). Interaction between SR1 and Hfq. Puriﬁed B. subtilis Hfq was added to ﬁnal concentrations as indicated
to three SR1 species of diﬀerent lengths comprising the 205, 186 or 104nt of 50 part of wild-type SR1 and binding was assayed as described in the
Materials and Methods section. (B). Interaction between ahrC RNA and Hfq. Puriﬁed B. subtilis Hfq was added to ﬁnal concentrations as indicated
to four ahrC species of diﬀerent length (see Figure 2C) and binding was assayed as in (A). (C). Complex formation between SR1 and ahrC RNA in
the absence and presence of puriﬁed B. subtilis Hfq. The interaction between SR1 (ﬁnal concentration: 1.0nM) and ahrC RNA was assayed in the
absence or presence of 10mM Hfq as described in the Materials and Methods section. The SR1/Hfq complex, the SR1/ahrC complex and the ternary
SR1/ahrC/Hfq complex are indicated. (D). Mapping of the Hfq-binding site on ahrC mRNA. Puriﬁed, 50 end-labelled ahrC483 RNA (13nM) was
incubated for 15min at 378C with increasing amounts of Hfq and subsequently subjected to limited cleavage with the RNases T1 and T2 followed by
separation on an 8% denaturing polyacrylamide gel. The autoradiogram is shown. RNase concentrations used were as in Figure 1. C, control
without RNase treatment, L, alkaline ladder. The Hfq-binding site is indicated by a black bar.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4341To reconcile these observations as well as the lacking
eﬀect of Hfq on SR1 stability with the increase of
the rocABC and rocDEF mRNA levels in the hfq
knockout strain, we tested whether the translation of
ahrC is aﬀected by Hfq. For this purpose, the ahrC-Bgab
translational fusion pGGA6 was integrated into the
amyE locus of DB104(hfq::cat), and b-galactosidase
activity was measured and compared to that determined in
the presence of Hfq in DB104. A 250-fold lower
b-galactosidase activity was detected in the absence of
Hfq, indicating that this RNA chaperone is required for
eﬃcient translation of ahrC mRNA in vivo (Table 2).
To substantiate the role of Hfq in promoting translation
of ahrC mRNA, the secondary structures of ahrC mRNA
and SR1 were probed with RNases T1 and T2 in the
presence and absence of Hfq. As shown in Figure 5D, one
binding site of Hfq on ahrC mRNA (50 AAAUA) is
located immediately upstream of the SD sequence. The
same assay was used to determine the binding site(s) of
Hfq on SR1. Here, one binding site around nt 9–13 in the
50 part of SR1 and a second in the bulge of stem-loop SL1
(nt 43 to 47) were found (gel not shown). The facts that
Hfq gel-shifts with wild-type SR1 and SR1104 comprising
only the 50 stem-loop were identical (Figure 5A), support
the absence of Hfq-binding sites on SR1 downstream from
nt 104.
SR1 blocks ribosome binding tothe ahrC mRNAtranslation
initiation region
Although the ﬁrst complementary region between ahrC
and SR1 is located 87nt downstream from the ahrC SD
sequence, we performed a toeprinting analysis (28) to
examine the eﬀect of SR1 on formation of the translation
initiation complex at ahrC mRNA. Figure 6A shows
that in the presence of initiator tRNA
fMet, 30S ribosomal
subunits bind to the ahrC translation initiation region and
block reverse transcription of a labelled primer, annealed
downstream, at the characteristic position +15 (start
codon A is +1). This signal provides a measure for the
formation of the ternary complex, since it is dependent on
both 30S subunits and initiator tRNA
fMet. Addition of
increasing amounts of SR1WT or SR1186 prior to addition
of 30S subunits and tRNA
fMet interfered with ternary
complex formation, resulting in a weaker toeprint signal
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Figure 6. Toeprinting analysis. Ternary complex formation upon addition of diﬀerent amounts of regulatory RNAs to either ahrC487 mRNA or sodB
mRNA (for details, see the Materials and Methods and Results section). The toeprint signal relative to A of the start codon is marked. Addition of
30S ribosomal subunits and initiator tRNA (lanes 2 and 3) as well as increasing concentrations (50-, 100- and 200-fold excess) of the regulatory
RNAs (lanes 4 to 6 and 7 to 9) are indicated above the gels. In all cases, the RNA sequencing reactions (C U G A) were carried out with the same
end-labelled oligonucleotide as in the toeprint analysis assays. (A) Toeprinting analysis with ahrC mRNA. An autoradiogram of ternary complex
formation on ahrC487 mRNA in the absence or presence of SR1 or heterologous small RNAs (SR2 from B. subtilis, RyhB from E. coli) is shown.
RyhB was added in a 200-fold excess. (B) Toeprinting analysis with sodB mRNA. An autoradiogram of ternary complex formation on sodB mRNA
in the absence or presence of SR1 or the cognate small RNA RyhB and the heterologous RNAIII (200-fold excess) from streptococcal plasmid
pIP501 is shown. (C) Toeprinting analysis of SR1186 and SR1186_G2. An autoradiogram of ternary complex formation on ahrC487 mRNA in the
absence or presence of SR1186 or SR1186_G2 carrying a 2-bp substitution in region G is shown. As negative controls, RyhB and RNAIII were added
in a 200-fold excess. (D) Calculation of the relative toeprints on ahrC487 mRNA with three SR1 species and heterologous RNA SR2.
4342 Nucleic Acids Research, 2007, Vol. 35, No. 13(Figure 6A and C). Thereby, the inhibitory activity of
SR1186 was higher than that of SR1WT which correlates
with its more eﬃcient binding activity to ahrC mRNA
(Figure 2). By contrast, both the addition of a noncognate
small RNA, SR2 from B. subtilis or RyhB from E. coli,
failed to decrease the toeprint signal on ahrC mRNA
(summarized in Figure 6D) indicating that SR1-dependent
inhibition of ribosome binding was speciﬁc. To support
the speciﬁcity of the SR1 inhibitory action on ternary
complex formation on ahrC mRNA, a control toeprint
was performed with SR1 and sodB mRNA (target of
RyhB). Since SR1 did not aﬀect ternary complex
formation on sodB mRNA (Figure 6B), whereas RyhB
did as expected, it can be excluded that the eﬀect of SR1
on ahrC mRNA is simply due to binding to the ribosome.
To corroborate the importance of complementary region
G for the interaction between SR1 and ahrC mRNA, an
additional toeprinting assay was carried out with the
G-region mutant SR1186_G2 compared to SR1186
(Figure 6C). The autoradiogram and the quantiﬁcation
(Figure 6D) show that this mutant is clearly impaired in
blocking the binding of the 30S initiation complex,
although it has still some residual activity. This result
conﬁrms both the speciﬁcity of the SR1/ahrC interaction
and substantiates our conclusion from the binding assays
(Figures 2 and 4) that G is required for the initial contact
between SR1 and ahrC mRNA. In summary, these data
demonstrate that binding of SR1 to ahrC mRNA prevents
the formation of translation initiation complexes.
The intracellular concentration of SR1increases about
10-foldin stationary phase
To determine the intracellular concentration of SR1 in
B. subtilis in logarithmic and stationary growth phase,
strain DB104 was grown in complex medium, and samples
were withdrawn at OD 2 (log phase) and OD 4.5 (onset of
stationary phase). Cell numbers were determined upon
plating of appropriate dilutions of the harvested cultures
on agar plates. Total RNA was prepared, separated on a
denaturing polyacrylamide gel alongside deﬁned amounts
of in vitro synthesized SR1 and subsequently, subjected
to northern blotting (Figure 7). Losses during RNA
preparation were calculated using in vitro synthesized SR1
mixed with the same amount of DB104::sr1 cells at the
beginning of the RNA preparation. A comparison with
the same amounts of untreated RNA yielded  80% loss.
Loading errors were corrected by reprobing with labelled
oligonucleotide C767 complementary to 5S rRNA.
Using this quantiﬁcation procedure, the amount of SR1
within one B. subtilis cell was calculated to be  20
molecules in log phase and 200–250 molecules in
stationary phase, corresponding to an approximate
intracellular concentration of 30 and 315nM, respectively.
DISCUSSION
For all recently discovered trans-encoded sRNAs the
targets of which have been identiﬁed, only one or two
complementary regions were found. In the majority of
cases, these regions covered the 50 part of the target RNA,
mostly including the SD sequence, and the mechanism of
action was found to be inhibition or activation of
translation initiation. Rather unusually, SR1 and ahrC
mRNA contain seven regions of complementarity that
comprise the 30 half of SR1 and the central and 30 portion
of ahrC mRNA (24). This prompted us to determine the
secondary structures of SR1 and the ahrC/SR1 complex
and to investigate the structural requirements for eﬃcient
ahrC/SR1 pairing.
Figure 1B shows that SR1 is composed of one large
50 stem-loop (SL1) structure with a prominent bulge, a
central small stem-loop SL2 and the terminator stem-loop
SL3 separated by two single-stranded regions. Six out of
seven regions of complementarity to ahrC RNA (B to G)
are located in the 30 100nt of SR1. Secondary structure
probing of labelled SR1 in complex with increasing
concentrations of unlabelled ahrC and vice versa
(Figure 3A and B) revealed structural alterations in six
of the seven complementary regions. In SR1, all positions
in region C and G as well as a few positions in B, D, E and
F were aﬀected (summarized in Figure 3C). In ahrC,
alterations in regions C, E, F and G as well as additional
alterations between regions D and E were found.
Interestingly, structural changes over a stretch of  50nt
were also observed upstream of region G (Figure 3B left),
although the ahrC SD sequence (nt 21 to 25) and the
start codon remained unaﬀected indicating that binding
of SR1 causes structural changes in the 50 part of
ahrC-mRNA, too.
Whereas for cis-encoded antisense RNAs from plas-
mids, phages and transposons, a number of studies have
been performed to elucidate binding pathways and to
determine structural requirements for the two contacting
RNA molecules (17), little is known, so far, about the
formation of initial contacts between trans-encoded
sRNAs and their targets. Here, we show that a solely
78-nt long SR1 species spanning nt 109 to 186 is suﬃcient
for eﬃcient complex formation with ahrC mRNA, i.e. the
50 portion of SR1 is not needed (Figure 2A). Generally, all
SR1 species lacking the 50 half of SL3 with region G or
1 234 5 5
OD 4.5
SR1
OD 2
1 2 3 455 5
5S rRNA
Figure 7. Intracellular concentration of SR1 under diﬀerent growth
conditions. Bacillus subtilis strain DB104 was grown to OD560=2 (log
phase) or OD560=4.5 (stationary phase), respectively, 5ml or 1.5ml
culture, respectively, were withdrawn and used for the preparation of
total RNA and subsequent northern blotting. Lanes 1 and 2, 6.6 and
33.3 fmol of in vitro synthesized, puriﬁed SR1, lanes 3 and 4, DB104
(sr1::cat) with 6.6 and 33.3 fmol of in vitro synthesized, puriﬁed SR1
mixed at the beginning of the RNA preparation, lanes 5, two and three
parallels of RNA isolated from DB104. An autoradiogram of the
northern blot is shown.
Nucleic Acids Research, 2007, Vol. 35, No. 13 4343comprising a complete SL3 were signiﬁcantly impaired
in pairing with ahrC RNA. This might indicate that
in vivo some factor — most likely a protein or an RNase
cutting within the loop of SL3 — opens the terminator
stem-loop to promote complex formation. Since in vivo
only full-length SR1205 can be observed (northern blots
and 30 RACE, 23), the involvement of an endoribonu-
clease is highly unlikely. The possibility that the RNA
chaperone Hfq that binds upstream of the terminator
stem-loop of SR1 is responsible for opening up this
structure, can be eliminated, too (see below). Most
probably, another, yet unknown RNA-binding protein is
needed to open SL3.
Two lines of evidence show that the initial contact
between SR1 and ahrC RNA occurs at complementary
region G of SR1: complex formation assays of truncated
SR1/ahrC pairs containing mutations and compensatory
mutations in region G (Figure 4) and translational ahrC-
lacZ reporter gene fusions with the same point mutations
(Table 2). Furthermore, complex formation assays with
SR1 mutants aﬀected in regions C, D, E/F or a
combination thereof and a lacZ fusion with regions E0,
F0 and G0 revealed a contribution of the other comple-
mentary regions to SR1/ahrC pairing. In summary, since,
(i) in the absence of region G, no eﬃcient complex could
form, (ii) in the presence of wild-type regions A to E, a
2-nt exchange within G inhibits pairing and (iii) in the
presence of G, signiﬁcant simultaneous alterations in
regions C, E and F did aﬀect complex formation, we can
conclude, that region G is responsible for the initial
contact between SR1 and ahrC RNA, but the other
complementary regions add to eﬃcient antisense/target
RNA pairing.
Region G0 in unpaired ahrC mRNA is double-stranded
with a bulged-out G at position 116 (Figure 3B left).
Interestingly, only when this G and the neighboured C
were replaced by a C and G (ahrC88_G2, see Figure 4), the
interaction with SR186_G2 was restored indicating that it is
crucial for the initial contact. As proposed above, some
factor is needed to melt or open up region G in SR1, so
that the two regions can interact. Our data suggest that
pairing initiates at G, but for subsequent steps and stable
complex formation, a contribution of the other comple-
mentary regions B to F is needed. This is reminiscent of
the binding pathway of the antisense/sense RNA pair
CopA/CopT involved in regulation of plasmid R1
replication [reviewed in (35)]. Here, binding starts with
the interaction of two single-stranded kissing loops and,
afterwards, a second region is needed to overcome the
torsional stress and to propagate the helix. By contrast,
for the antisense/sense RNA pair RNAIII/RNAII of
plasmid pIP501, the simultaneous interaction of two
complementary loop pairs was found to be required
(36). In other cases, a single-stranded region and a loop
form the ﬁrst complex [e.g. Sok/hok of plasmid R1 or
RNA-OUT/RNA-IN of transposon IS10, reviewed
in (17)].
For many trans-encoded sRNAs in E. coli, the RNA
chaperone Hfq has been shown to be required for
either stabilization of the sRNA or/and eﬃcient duplex
formation with the target RNA (see the Introduction
section). Previous experiments have demonstrated that
Hfq does not stabilize SR1 (24). This report shows that
although B. subtilis Hfq binds both SR1 and ahrC RNA, it
is not able to promote complex formation between SR1
and ahrC (Figure 5). This is in agreement with data
obtained for the RNAIII/spa interaction in S. aureus, for
which Hfq was found to be dispensable for RNAIII/spa
complex formation (22,16). The fact that no requirement
for Hfq was observed in the RatA/txpA system of
B. subtilis (3), too, suggests that in Gram-positive bacteria
Hfq might not be needed for sRNA/target RNA interac-
tion or, alternatively, that another RNA chaperone may
fulﬁl the function of Hfq. One candidate might be HBsu,
for which RNA-binding activity was demonstrated (37).
However, our previous observation that the levels of the
secondary targets of SR1, rocABC and rocDEF mRNA,
were increased 3- to 6-fold in an hfq knockout strain (24)
raised the question on the role of this chaperone in the
SR1/ahrC system. Suprisingly, ahrC mRNA proved to be
not translated in a B. subtilis hfq knockout strain
(Table 2). This indicates that Hfq is required for eﬃcient
translation of ahrC, possibly by opening up some
secondary structures that otherwise inhibit binding of
the 30S initiation complex. This is supported by the
ﬁnding of one Hfq-binding site (50 AAAUA) immediately
upstream of the ahrC ribosome-binding site (RBS).
Interestingly, for E. coli rpoS mRNA it has been also
shown that Hfq is essential for eﬃcient translation (38).
In contrast to ahrC, the binding of Hfq to SR1 does not
seem to play a role in this context. The fact that Hfq binds
upstream of six out of seven SR1 regions complementary
to ahrC mRNA supports the failure of Hfq to promote
complex SR1/ahrC formation. However, we cannot
exclude that Hfq binding might be important for the
interaction of SR1 with other, still unidentiﬁed target
mRNAs.
Based on a series of translational ahrC-lacZ fusions, the
dispensability of the ahrC SD sequence for pairing with
SR1 and in vitro translation data with chimeric ahrC/sodB
RNAs, we suggested previously that SR1 might aﬀect
ahrC translation at a post-initiation stage (24). However,
the structural alterations found in the ahrC mRNA
downstream from the SD sequence in the presence of
increasing amounts of SR1 prompted us to re-evaluate
our previous data using a toeprinting analysis (Figure 6).
Both SR1WT and SR1186, but not two heterologous
RNAs, were able to inhibit binding of the 30S ribosomal
subunit and formation of a ternary complex with 30S and
tRNAf
Met on full-length ahrC mRNA. These results —
together with the structure probing data — demonstrate
that binding of SR1 induces structural changes in a  65-nt
long stretch of ahrC RNA between SD sequence and
complementary region G that eventually inhibit formation
of the 30S initiation complex. Since the 30S ribosomal
subunit covers 54nt, i.e. 35 ( 2) nt upstream and 19nt
downstream from the start codon (39), the 50 part of the
SR1-induced structural alterations of ahrC mRNA coin-
cides exactly with this region. The analysis of the G region
mutant SR1186_G2 in the toeprinting assay (Figure 6C)
corroborated that this region is involved in the ﬁrst
contact between SR1 and ahrC mRNA and supported
4344 Nucleic Acids Research, 2007, Vol. 35, No. 13the speciﬁc basepairing interaction between both
RNA molecules. The toeprinting results are not opposed
to the previously observed translation inhibition of ahrC-
lacZ fusions (24), as this inhibition can be explained by
SR1-induced structural changes in the 50 part of ahrC
RNA, too. Therefore, we can conclude that the
mechanism of action employed by SR1 is inhibition of
translation initiation. This is the ﬁrst case of a small
regulatory RNA that binds  90nt downstream from the
ribosome-binding site and interferes with translation
initiation. In contrast, in the well-studied E. coli systems
like RyhB/sodB (20) or MicA/ompA (14,21), the comple-
mentary regions between small RNA and mRNA are
located upstream of or overlap the target SD sequence,
making an eﬀect on ribosome binding and hence,
translation initiation, more plausible. Our results raise
the question on the maximal distance between SD
sequence and a binding region for a small RNA permitting
to aﬀect 30S subunit binding. Furthermore, in many
E. coli cases the inhibition of translation initiation was
accompanied by signiﬁcantly decreased amounts of the
target mRNA(s) [e.g. RyhB/sodB (40) or SgrS/ptsG (41)]
that was attributed to degradation of the unprotected
target RNA by RNase E or of the complex by RNase III
(42). Surprisingly, ahrC levels were found to be indepen-
dent of the presence or absence of SR1 (24). To date, no
RNase E has been found in B. subtilis. Although two
novel endoribonucleases with homology to RNase E,
RNase J1 and J2, were recently discovered (43), it is
unclear, whether they fulﬁl the role of the main
endoribonucleases as it does RNase E in Gram-negative
bacteria.
In the few sense/antisense RNA systems, where
calculations of the amount of both interacting species
were performed (44,45), an at least 10-fold excess of the
inhibitory small RNA over its target was determined.
Here, the amount of SR1 in B. subtilis grown in complex
medium was found to increase upon entry into stationary
phase from 15–20 to 250 molecules per cell. This is much
lower than the 4500 molecules measured for OxyS under
oxidative stress conditions (30), but still in the range of
RNAIII of plasmid pIP501 ( 1000 molecules). Since
we could not detect ahrC mRNA in northern blots under
any growth condition, its amount must be signiﬁcantly
lower than 15 molecules/cell ensuring at least a 15-fold
excess of SR1.
The analysis of the SR1/ahrC mRNA interaction
yielded three major issues, which might be important for
sRNA/target RNA systems in general: First, whereas the
major mechanism of action of trans-encoded sRNAs
reported in Gram-negative bacteria is inhibition of
translation initiation by direct binding to the RBS or
50 of it, the B. subtilis SR1/ahrC pair is ﬁrst case, where
translation initiation is prevented by binding of the sRNA
 90nt downstream from the RBS. Second, while all
sRNA/target RNA pairs studied so far comprise at the
most two complementary regions, the SR1/ahrC pair is the
ﬁrst case with seven complementary regions between
inhibitor and target RNA, and the major contribution
of one region as well as the minor, but measurable
contribution of ﬁve of the other regions has been
demonstrated. Third, whereas in E. coli, Hfq was required
for either sRNA stabilization or promotion of complex
formation with the target RNA, at least complex
formation in Gram-positive bacteria does not seem to
depend on Hfq. The search for and analysis of other SR1
targets will reveal whether this sRNA exerts its function(s)
by the same or alternative mechanisms.
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